In the third and final episode of Florida Capital Conversations' healthcare privacy series, Tallahassee attorneys Shannon Hartsfield and ...

Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials National estimates of cancer ...

A diet trial becomes reasonable when pruritus is persistent and nonseasonal or when standard atopy treatments fail over ...

For decades Black patients have been underrepresented in clinical trials of new treatments. In response, in 2015 the Food and Drug Administration (FDA) launched a five-year action plan aimed at ...

By elevating patient perspectives from an afterthought to a core part of the process, payers can create a system that aligns ...

uw.edu Yet few healthcare institutions see patient complaints as adverse events. Instead, at most institutions, patient complaints are handled by patient relations or risk management departments, with ...

today announced the completion of patient enrollment and the last patient dosed in RECONNECT, a Phase 2 clinical trial evaluating RE104 in adult female patients with moderate-to-severe postpartum ...

The partnership aims to revolutionize oncology trials by improving trial operations, speeding up data delivery, and accelerating access to advanced therapies for patients worldwide. The ...

“A lot of them just don’t like taking us as patients.” The lack of a biomarker has also stymied clinical trials looking for evidence of improvements, researchers said. “There really needs ...

A Chinese startup has opened the world’s first clinic in Saudi Arabia where artificial intelligence diagnoses patients, a key step in replacing human doctors as the first line of medical treatment.

Major study milestone highlights START's commitment to bringing novel cancer therapies to patients through community-based early-phase clinical trials SAN ANTONIO, May 15, 2025 /PRNewswire/ -- The ...

The pivotal clinical trial is designed to include a core population of patients with NSCLC carrying RAS mutations at position G12 (G12X), and an expanded population that also includes patients with ...